BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16600178)

  • 1. Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3.
    Karlsen AE; Størling ZM; Sparre T; Larsen MR; Mahmood A; Størling J; Roepstorff P; Wrzesinski K; Larsen PM; Fey S; Nielsen K; Heding P; Ricordi C; Johannesen J; Kristiansen OP; Christensen UB; Kockum I; Luthman H; Nerup J; Pociot F
    Biochem Biophys Res Commun; 2006 May; 344(1):406-15. PubMed ID: 16600178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a cocktail regimen consisting of soluble galectin-1, rapamycin and histone deacetylase inhibitor may effectively prevent type 1 diabetes.
    Jiang GX; Cui YF; Zhong XY; Tai S; Liu W; Wang ZD; Shi YG
    Arch Med Res; 2009 Jul; 40(5):424-6. PubMed ID: 19766909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is mortalin a candidate gene for T1DM ?
    Johannesen J; Pie A; Karlsen AE; Larsen ZM; Jensen A; Vissing H; Kristiansen OP; Pociot F; Nerup J; ;
    Autoimmunity; 2004; 37(6-7):423-30. PubMed ID: 15621568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional profiling of type 1 diabetes genes on chromosome 21 in a rat beta-cell line and human pancreatic islets.
    Bergholdt R; Karlsen AE; Hagedorn PH; Aalund M; Nielsen JH; Kruhøffer M; Orntoft T; Wang H; Wollheim CB; Nerup J; Pociot F
    Genes Immun; 2007 Apr; 8(3):232-8. PubMed ID: 17330137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-interleukin-1 in type 1 diabetes action trial--background and rationale.
    Pickersgill LM; Mandrup-Poulsen TR
    Diabetes Metab Res Rev; 2009 May; 25(4):321-4. PubMed ID: 19405081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico identification of NF-kappaB-regulated genes in pancreatic beta-cells.
    Naamane N; van Helden J; Eizirik DL
    BMC Bioinformatics; 2007 Feb; 8():55. PubMed ID: 17302974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of expression and secretion of galectin-3 in human monocyte-derived dendritic cells.
    van Stijn CM; van den Broek M; van de Weerd R; Visser M; Taşdelen I; Tefsen B; van Die I
    Mol Immunol; 2009 Oct; 46(16):3292-9. PubMed ID: 19699526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine signalling in the beta-cell: a dual role for IFNgamma.
    Gysemans C; Callewaert H; Overbergh L; Mathieu C
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):328-33. PubMed ID: 18481951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells.
    Souza KL; Gurgul-Convey E; Elsner M; Lenzen S
    J Endocrinol; 2008 Apr; 197(1):139-50. PubMed ID: 18372240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice.
    Mensah-Brown EP; Al Rabesi Z; Shahin A; Al Shamsi M; Arsenijevic N; Hsu DK; Liu FT; Lukic ML
    Clin Immunol; 2009 Jan; 130(1):83-8. PubMed ID: 18845486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro.
    Saksida T; Nikolic I; Vujicic M; Nilsson UJ; Leffler H; Lukic ML; Stojanovic I; Stosic-Grujicic S
    J Cell Physiol; 2013 Jul; 228(7):1568-76. PubMed ID: 23280610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling by IL-1beta+IFN-gamma and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic beta-cell apoptosis.
    Gurzov EN; Ortis F; Cunha DA; Gosset G; Li M; Cardozo AK; Eizirik DL
    Cell Death Differ; 2009 Nov; 16(11):1539-50. PubMed ID: 19629134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes.
    Honkanen J; Skarsvik S; Knip M; Vaarala O
    Diabetes Metab Res Rev; 2008; 24(8):635-41. PubMed ID: 18973208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NF-kappaB in beta-cell death.
    Melloul D
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):334-9. PubMed ID: 18481952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined genome and proteome approach to identify new susceptibility genes.
    Pociot F; Karlsen AE
    Am J Med Genet; 2002 May; 115(1):55-60. PubMed ID: 12116177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells.
    McKenzie MD; Carrington EM; Kaufmann T; Strasser A; Huang DC; Kay TW; Allison J; Thomas HE
    Diabetes; 2008 May; 57(5):1284-92. PubMed ID: 18252892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
    Ghanaat-Pour H; Sjöholm A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells.
    Kang JH; Chang SY; Jang HJ; Kim DB; Ryu GR; Ko SH; Jeong IK; Jo YH; Kim MJ
    J Endocrinol; 2009 Jul; 202(1):65-75. PubMed ID: 19398497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.